Identifying patients' MS early is key to preventing or delaying disability. MS specialist Robert Shin, MD, shares how.
Category: Neurology
Shayan Moosa, MD, shares how this therapy holds promise for glioblastoma and other brain cancers and disorders.
Learn how Karen Johnston, MD, is working to speed up translational research and uncovering better interventions for victims of large strokes.
Using advanced neuromonitoring and mapping techniques to distinguish diseased and healthy tissue dramatically reduces the risk of postoperative neurological deficits.
Binit Shah, MD, shares how our new multidisciplinary clinic can improve your patients' quality of life.
Researchers are building on groundbreaking work published in 2019 that set the standard for treating patients who fail first-line therapy.
Research on how spreading depolarizations cause secondary injury in early recovery could be the tip of the iceberg in finding new treatments for a range of brain-related conditions.
Recent analysis from the SHINE trial has found a link between high blood sugar after thrombolysis and life-threatening brain bleeds, especially in patients with severe strokes.
Researchers believe understanding mutations in ER protein translocation and processing complexes will lead to improved treatments for patients with congenital disorders of glycosylation.
UVA Health's Pituitary Tumor Program ensures optimal patient outcomes through collaboration, cutting-edge techniques, and streamlined care pathways.